FDA
-
-
-
-
-
-
-
CytoDyn Announces President Takes Medical Leave of Absence
-
-
-
-
-
-
-
CytoDyn Announces Resolution of Legal Dispute with Former Chief Medical Officer
-
-
-
-
-
-
-
Regnum Signs Assignment and Assumption Agreement with CytoDyn and SevenScore Pharmaceuticals to Commercialize Leronlimab in the U.S. for the Treatment of HIV
-
-
-
-
-
-
-
CytoDyn Submits Protocol with the FDA for Phase 3 Registrational Trial of Leronlimab for Critically Ill COVID-19 Population
-
-
-
-
-
-
-
CytoDyn Research Paper on Leronlimab Published in Frontiers in Immunology Journal
-
-
-
-
-
-
-
CytoDyn Inc. Announces Adjournment of Annual Meeting of Shareholders to November 24, 2021 Due to Lack of Quorum
-
-
-
-
-
-
-
Delaware Court Agrees with CytoDyn that Activist Group’s Nominations are Invalid
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

